32 results
8-K
EX-99.1
INZY
Inozyme Pharma Inc
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, or by email at: dg.prospectus_requests@bofa.com; TD Cowen, 599 Lexington … Avenue, New York, NY 10022, or by email at Prospectus_ECM@cowen.com or by telephone at (833) 297-2926; or Piper Sandler, Attention: Prospectus Department
8-K
EX-1.1
INZY
Inozyme Pharma Inc
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
. Department of the Treasury’s Office of Foreign Assets Control or the U.S. Department of State), the United Nations Security Council, the European … by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other governmental or foreign regulatory entity
8-K
EX-99.1
kux8tca9y z643
19 Apr 22
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
7:30am
8-K
EX-1.1
9gos4lmqpey3nn5
19 Apr 22
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
7:30am
S-3
EX-1.2
uas8vns
11 Aug 21
Shelf registration
7:12am
DEF 14A
jqfo7vswh0f6 wc1
27 Apr 21
Definitive proxy
7:30am
10-K
smjyqe6l
25 Mar 21
Annual report
6:21am
10-Q
t8pskfq
3 Sep 20
Quarterly report
4:19pm
424B4
xqdwce6 dpjf5uitp3
24 Jul 20
Prospectus supplement with pricing info
4:01pm
FWP
vwle0
23 Jul 20
Free writing prospectus
9:42am
S-1/A
6ee9usl8b7e3r30 qdi
20 Jul 20
IPO registration (amended)
6:09am